Zhang S, Danielsen M
Department of Biochemistry and Molecular Biology, Georgetown University Medical School, 3900 Reservoir Road, N.W., 20007, Washington, DC, USA.
Endocrine. 1995 Jan;3(1):5-12. doi: 10.1007/BF02917442.
RU486 has been reported to be a glucocorticoid receptor (GR) and a progesterone receptor (PR) antagonist. We have analysed RU486 activity on the GR in WCL-2 (CHO) cells and in COS-7 cells transiently transfected with the mouse GR and with the reporter MMTVCAT (MCAT). These cell lines do not contain any active progesterone or androgen receptors. In both cell lines RU486 is a partial agonist of the GR with 10-15% of the activity of dexamethasone. As expected, RU486 is also a partial antagonist of the GR. Treatment of COS-7 cells with 8-Br-cAMP increases the agonist activity of both dexamethasone and RU486. This cAMP induced superactivation is seen with all steroids that have full or partial agonist activity. In contrast, the activities of ZK98.299 and R5020, which are complete antagonists of the GR without any agonist activity, are not affected by 8-Br-cAMP treatment. This effect of 8-Br-cAMP is not seen in WCL2 cells. 8-Br-cAMP, therefore, is not a switch which changes antagonists to agonists but is, rather, a cell specific activator of all agonists whether they have full or only partial agonist activity.
据报道,米非司酮是一种糖皮质激素受体(GR)和孕酮受体(PR)拮抗剂。我们分析了米非司酮对WCL-2(CHO)细胞以及瞬时转染了小鼠GR和报告基因MMTVCAT(MCAT)的COS-7细胞中GR的活性。这些细胞系不含有任何活性孕酮或雄激素受体。在这两种细胞系中,米非司酮都是GR的部分激动剂,其活性为地塞米松的10 - 15%。正如预期的那样,米非司酮也是GR的部分拮抗剂。用8-溴环磷腺苷(8-Br-cAMP)处理COS-7细胞会增加地塞米松和米非司酮的激动剂活性。这种由cAMP诱导的超活化在所有具有完全或部分激动剂活性的类固醇中都能看到。相比之下,ZK98.299和R5020是GR的完全拮抗剂,没有任何激动剂活性,它们的活性不受8-Br-cAMP处理的影响。在WCL2细胞中未观察到8-Br-cAMP的这种作用。因此,8-Br-cAMP不是将拮抗剂转变为激动剂的开关,而是所有激动剂(无论其具有完全还是仅部分激动剂活性)的细胞特异性激活剂。